TAK-285

TAK-285
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T6039-1mg 1 mg

7 - 10 business days*

31.00€
TGM-T6039-5mg 5 mg

7 - 10 business days*

69.00€
TGM-T6039-1mL 1 ml

7 - 10 business days*

83.00€
TGM-T6039-10mg 10 mg

7 - 10 business days*

115.00€
TGM-T6039-25mg 25 mg

7 - 10 business days*

215.00€
TGM-T6039-50mg 50 mg

7 - 10 business days*

351.00€
TGM-T6039-100mg 100 mg

7 - 10 business days*

509.00€
TGM-T6039-200mg 200 mg - - -

7 - 10 business days*

725.00€
 
Description: TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM,... more
Product information "TAK-285"
Description: TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM, >10-fold selectivity for HER1/2 than HER4, less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc. Phase 1. Target: MEK, EGFR, Aurora Kinase, HER. Smiles: CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(c4)C(F)(F)F)c(Cl)c3)c12. References: Erdo F, et al. Brain Res Bull, 2012, 87(4-5), 413-419.
Keywords: TAK285 , TAK 285
Supplier: TargetMol
Supplier-Nr: T6039

Properties

Application: EGFR / HER2 dual inhibitor
MW: 547.96 D
Formula: C26H25ClF3N5O3

Database Information

CAS : 871026-44-7| Matching products
KEGG ID : K04361 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "TAK-285"
Write a review
or to review a product.
Viewed